Note: Ingredients listed on restricted chemical lists
EC/CAS
107-21-1
Name of the chemical
Ethane-1,2-diol
Concentration
30-60
EC/CAS
8007-18-9
Name of the chemical
Antimony nickel titanium oxide yellow
Concentration
30-60
General Information
Version
3
Revision date
2026-09-03
Product name
BASES 0901/V7191 YELLOW PIGMENT PASTE W/B
1.2.1 Relevant identified uses
Industrial applications
Manufacturer Name
PPG Industries, Inc
Icons in SDS
Company Information
company name
PPG Industries, Inc
GHS Information
Signal word
Warning
Hazard Codes
Hazard statements (CLP)
H302, H319, H373
Hazard statements
Code
Statements
H302
Harmful if swallowed
H319
Causes serious eye irritation
H373
May cause damage to organs through prolonged or repeated exposure
Section 2
SECTION 2: Hazards identification
Ingredient(s) with unknown acute toxicity
45% (oral), 45% (dermal), 87.9% (inhalation)
Signal word
Warning
Hazard statements
Harmful if swallowed. Causes serious eye irritation. May cause damage to organs through prolonged or repeated exposure. (kidneys)
Prevention
Wear eye or face protection. Do not breathe vapor. Do not eat, drink or smoke when using this product. Wash thoroughly after handling.
Response
IF SWALLOWED: Call a POISON CENTER or doctor if you feel unwell. Rinse mouth. IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing. If eye irritation persists: Get medical advice or attention.
Storage
Not applicable.
Disposal
Dispose of contents and container in accordance with all local, regional, national and international regulations.
Supplemental label elements
Avoid contact with skin and clothing. Wash thoroughly after handling. Emits toxic fumes when heated.
2.3 Other hazards
Prolonged or repeated contact may dry skin and cause irritation.
2.1 Classification of the substance or mixture
EYE IRRITATION - Category 2A SPECIFIC TARGET ORGAN TOXICITY (REPEATED EXPOSURE) - Category 2 Percentage of the mixture consisting of ingredient(s) of unknown acute toxicity: 45% (oral), 45% (dermal), 87.9% (inhalation)